AR-17043/Latanoprost

N/A

Report date: 2024/06/11 20:00:08
NME

Base Information

Drug NameAR-17043/Latanoprost
Drug Alias NamePG043PG-043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor agonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes AR-17043Latanoprost
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesAlcon
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A